Inventor · disambiguated record
Adam Ross Patterson
Also filed as: PATTERSON ADAM · PATTERSON ADAM ROSS
3 granted patents·4 pending applications·2 citations·filing 2020–2024
53Inventor score
Files withCARDURION PHARMACEUTICALS INC2JOHNSON MATTHEY PLC2H LUNDBECK AS1MACFARLAN SMITH LTD1SYNDESI THERAPEUTICS SA1
Top patents by PatentIndex Score
7 records- 0183US12006319B2Monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-oneCARDURION PHARMACEUTICALS INC·Filed 2020·Granted Jun 11, 2024·2 cites·20 claims
- 0268US12466832B2Monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-oneCARDURION PHARMACEUTICALS INC·Filed 2024·Granted Nov 11, 2025·0 cites·11 claims
- 0359US12152029B2Crystalline forms of a MAGL inhibitorH LUNDBECK AS·Filed 2022·Granted Nov 26, 2024·0 cites·25 claims
- 0453US2021361626A1Crystalline productJOHNSON MATTHEY PLC·Filed 2021·Application pending·0 cites
- 0551US2023068593A1Processes for preparing tucatinib polymorphsMACFARLAN SMITH LTD·Filed 2022·Application pending·0 cites
- 0651US2024132478A1CocrystalSYNDESI THERAPEUTICS SA·Filed 2021·Application pending·0 cites
- 0745US2022372024A1Crystalline forms of entrectinibJOHNSON MATTHEY PLC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →